News Feed
The American Cancer Society Awards $217,500 to Pennington Biomedical Researcher for Study on How Aerobic Exercise Impacts Colorectal Cancer Survivors
The American Cancer Society, the largest non-government, non-profit funding source of cancer research in the United States, has approved funding for $28 million in new Extramural Discovery Science research and career development grants. The awards will fund investigators at institutions across the United States starting in July 2024.
Learn More
Pennington Biomedical Research Presented at NUTRITION 2024 in Chicago
NUTRITION 2024, the annual flagship meeting of the American Society of Nutrition, is taking place June 29-July 2 in Chicago, and a number of research findings from the Pennington Biomedical Research Center will be presented during the conference.
Learn More
Louisiana Obesity Society Conference Set for Aug. 10 in New Orleans
The Louisiana Obesity Society and the Louisiana Chapter of the American Society for Metabolic and Bariatric Surgery are happy to announce the 2024 Louisiana Obesity Conference on Saturday, Aug. 10, in New Orleans at the Renaissance Arts Hotel. Keynote speakers for the event are anticipated to include Senator Bill Cassidy, MD; Dr. Jamy Ard, President of The Obesity Society; and Dr. Ann Rogers, President-Elect of the American Society for Metabolic and Bariatric Surgery.
Learn More
New Findings from ARMMS-T2D Study Continue to Show Benefits of Metabolic/Bariatric Surgery Over Medical Interventions for those with Type 2 Diabetes
The 12-year Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes, or ARMMS-T2D, clinical trial continues to provide significant findings on the benefits of bariatric surgery over medical management, as presented during the 84th annual American Diabetes Association Scientific Sessions in Orlando, Fla.
Learn More
Pennington Biomedical Researchers Partner on Award-Winning Long Covid Study
Dr. John Kirwan, Executive Director of Pennington Biomedical Research Center, is serving as a co-principal investigator on the Pathobiology in RECOVER of Metabolic and Immune Systems, or PROMIS, study. The study has been awarded more than $802,000 by the National Institutes of Health to identify potential causes of Long COVID.
Learn More
Pennington Biomedical Research Presented at the 84th Annual American Diabetes Association Scientific Sessions
The 84th annual American Diabetes Association Scientific Sessions are taking place June 21-24 in Orlando, Fla., and several research findings from the Pennington Biomedical Research Center will be presented during the conference.
Learn More
Small Shifts for Nutritional Health
Once a person decides it’s time to lose some weight, it may be difficult to determine what’s the best option for them. With all the diet noise out there, what’s the best way to take off those unwanted pounds—and keep them off?
Learn More
Pre-Operative Use of GLP-1s May Reduce Complications After Metabolic and Bariatric Surgery in Patients with Extreme Obesity
A combination of GLP-1 agonists taken before metabolic and bariatric surgery may help patients with extreme obesity lower the risk of post-operative complications, according to a new study* presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2024 Annual Scientific Meeting
Learn More
Pennington Biomedical Research Center Recruiting Participants for Lipedema Research Study
June has been designated as Lipedema Awareness Month, and the month serves as an opportunity to educate the public about this common condition and raise funds for research. Lipedema, a condition defined by abnormal fat accumulation in certain parts of the body, most commonly the buttocks and thighs, is often misdiagnosed as obesity. This chronic and progressive condition primarily affects as many as one-in-10 women, and there is currently no cure and only limited therapies.
Learn More
Pennington Biomedical, Additional LSU Institutions Receive Major Grant for First Athletic Research Center in Louisiana
Pennington Biomedical researchers, and a team of clinicians and staff were selected to receive a research grant from the LSU Provost’s Fund for Innovation in Research to establish Louisiana’s first center for athletic research. The 2024 Provost’s Fund for Innovation is the largest internal funding program in LSU history, investing $1.2 million in interdisciplinary research teams. The team will be led by Dr. Guillaume Spielmann, who is an assistant professor in the LSU School of Kinesiology and an adjunct assistant professor at Pennington Biomedical. The research team also includes the Director of Pennington Biomedical’s Behavior Technology Laboratory, Dr. Tiffany Stewart.
Learn More
Pennington Biomedical Research Center Hosts Team for LSU Health Shreveport for Scientific Exchange, Future Collaboration
Pennington Biomedical hosted a team of researchers from LSU Health Shreveport on Friday, May 31, for a scientific exchange and to explore potential for research collaborations related to metabolic health.
Learn More
Since 2011, U.S. News & World Report Has Rated the DASH Diet Among the Top in the Best Diet Overall and Best Diet for Healthy Eating
Looking for a healthy eating plan? Why not try the DASH Diet, developed in part by Pennington Biomedical Research Center and ranked as one of U.S. News & World Report’s Best Diets since 2011. The American Heart Association also ranks the DASH Diet as the top heart-healthy eating style.
Learn More
Pennington Biomedical’s Dr. Robert Kesterson Working to Advance Knowledge of Neurofibromatosis Development and Treatment
Neurofibromatosis type 1, a genetic condition that causes tumors to grow along nerves, occurs in 1 in 3,000 to 4,000 people worldwide. Although the tumors are usually benign, they can cause blindness, deafness, disfigurement, bone abnormalities, learning disabilities, and disabling pain. Neurofibromatosis 1, more commonly called NF1, is also associated with an increased risk of other tumors including leukemia, glioblastoma, and breast cancer.
Learn More
Weight Loss Benefits of Semaglutide Last up to Four Years
Semaglutide, the much-acclaimed key ingredient in weight loss drugs Wegovy, Ozempic and Rybelsus, has been shown to deliver benefits that last up to four years and, on average, result in a weight reduction of 10 percent compared to placebos. These extended benefits were observed in data generated through the SELECT study, led by Pennington Biomedical Research Center’s professor emeritus Dr. Donna Ryan.
Learn More
Pennington Biomedical Professor Emeritus Dr. George Bray Publishes 100-Year History of Obesity Research
Dr. George Bray has dedicated his professional life to researching obesity and metabolism, serving as the first executive director of Pennington Biomedical Research Center in 1989. Now as professor emeritus, his most recent publication explores the extensive history of obesity research over the past 100 years and prior.
Learn More
Changing the Culture: Eating for You, Not for Two
For many generations, society has embraced the idea that pregnant women are “eating for two.” That adage is frequently invoked as mothers-to-be are encouraged to abandon diets and overindulge in every food craving in the name of nutrition.
Learn More
Dr. Leanne Redman to Lead Pennington Biomedical’s Nutrition Obesity Research Center
Dr. Leanne Redman has been named as the new director of Pennington Biomedical’s Nutrition Obesity Research Center, or NORC. On May 1, Dr. Redman took over the role from Dr. Eric Ravussin, who held the director position for 19 years. NORC is funded by the National Institute of Diabetes and Digestive and Kidney Diseases, or NIDDK, of the National Institutes of Health
Learn More
2024 Scientific Retreat Showcased Some of the Best of Pennington Biomedical
The annual Pennington Biomedical Scientific Retreat was held on May 1 in the C.B. Pennington Conference Center, and featured Blitz Presentations, Scientific Poster displays, guest speakers and much more. The Publication of the Year Award was also presented, filling the event with some of the very best research efforts by Pennington Biomedical researchers and scientists. LSU President Dr. William Tate attended the event and served as a guest speaker, sharing how Pennington Biomedical research is a vital node in the network of research across the LSU system.
Learn More
Bringing Scientists Back Home to Louisiana
Efforts to retain Louisiana’s best and brightest high school students in state often make the headlines. However, less attention is focused on how to keep those brilliant minds in the Bayou State after they complete undergraduate, master’s or Ph.D. programs. Over the past 35 years, Pennington Biomedical has attracted researchers from around the world to its Baton Rouge campus with the purpose of helping people live longer, healthier lives. These internationally renowned scientists collaborate with their colleagues in 240 academic institutions in 24 countries. Their work has generated close to 400,000 citations in scientific literature with five scientists ranking among the most cited researchers in the world
Learn More
During Mental Health Awareness Month, Practice Small Shifts for Mental Health and Resilience
May has been designated as Mental Health Awareness Month, and during the month, Pennington Biomedical’s Small Shifts campaign is focuses on mental health and resilience.
Learn More
